NCT01606709View on ClinicalTrials.gov

Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation

PHASE4TerminatedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Endometrial ReceptivityOvarian Hyperstimulation Syndrome

Interventions

DRUG

GnRH agonist

GnRH agonist 1mg one dose

DRUG

hCG

5,000 IU one dose

Trial Locations (1)

06030

UCHC Division of Reproductive Endocrinology, Farmington

Sponsors

Collaborators (1)

Schering-Plough

All Listed Sponsors

collaborator

Schering-Plough

INDUSTRY

lead

UConn Health

OTHER